pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 9·1 min read
save

Oura and Whoop add in-app virtual doctor visits, moving wearable data toward clinical use

Jun 9, 2026·read at STAT ↗Neutral

Wearable makers Oura and Whoop announced that users will soon be able to connect with doctors through their apps, allowing virtual consultations when a device flags a health concern.

The new feature aims to bridge the gap between consumer health data and clinical guidance, a step many see as essential for turning continuous monitoring into actionable medical insight.

Experts note that while the move is promising, the standards for using wearable data in clinical decisions are higher than for wellness tracking, and the FDA has approved only a few wearable functions for medical use so far.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic”

read at STAT ↗
602 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Psychiatry & CNS2Oncology

related stories

  • May 6Dr Chari on Frontline Combinations and Transplant Approaches in Multiple Myelomaonclive
  • May 6Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Canceronclive
  • May 6Dr Herrera on the Significance of the FDA Approval of Nivolumab Plus AVD for Classical Hodgkin Lymphomaonclive
  • May 6Dr Sznol on Biomarkers of Response in Metastatic Melanomaonclive
  • May 6Transformational Utah Investment in Artificial Intelligence and Computing to Advance Health and Discoveryonclive